Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients

Clinical Nutrition

Volumn 25, Issue 5, 2006, Pages 711-715

  Mateen, Farrah ^a   Jatoi, Aminah ^a  

^a Mayo Clinic   (United States)

Author keywords

Anorexia; Cancer; Megestrol acetate; Palliation

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; PLACEBO;

ADVANCED CANCER; ANOREXIA; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG DOSE REGIMEN; HUMAN; INCREASED APPETITE; LUNG SMALL CELL CANCER; MYOPATHY; NUTRITIONAL SUPPORT; PANCREAS CANCER; REVIEW; STOMACH IRRITATION; SYMPTOM; WEIGHT GAIN;

ANOREXIA; ANTINEOPLASTIC AGENTS, HORMONAL; BODY WEIGHT; HUMANS; MEGESTROL ACETATE; NEOPLASMS; PALLIATIVE CARE; WEIGHT GAIN;

EID: 33748909570     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.05.009     Document Type: Review

References (15)

1. Tchekmedyian N.S., Tait N., Moody M., and Aisner J. High-dose megestrol acetate. A possible treatment for cachexia. JAMA 257 (1987) 1195-1198
2. Tranmer J.E., Heyland D., Dudgeon D., Groll D., Squires-Graham M., and Coulson K. Measuring the symptom experience in seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 25 (2003) 420-429
3. Wolfe J., Grier H.E., Klar N., et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342 (2000) 326-333
4. Tamburini M., Brunelli C., Rosso S., and Venafridda V. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 11 (1996) 32-41
5. Loprinzi C.L., Laurie J.A., Wieand H.S., et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 12 (1994) 601-607
6. Dewys W.D., Begg C., Lavin P.T., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 (1980) 491-497
7. Loprinzi C.L., Ellison N.M., Schaid D.J., et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82 (1990) 1127-1132
8. Jatoi A., Kumar S., Sloan J.A., and Nguyen P.L. On appetite and its loss. J Clin Oncol 21 Suppl 9 (2003) 79-81
9. Rowland K.M., Loprinzi C.L., Shaw E.G., et al. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol 14 (1996) 135-141
10. Loprinzi C.L., Schaid D.J., Dose A.M., Burnham N.L., and Jensen M.D. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 11 (1993) 152-154
11. Kotler D.P., Tierney A.R., Wang J., and Pierson R.N. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50 (1989) 444-447
12. Jatoi A., Rowland K., Loprinzi C.L., et al. North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22 (2004) 2469-2476
13. Jatoi A., Windschitl H.E., Loprinzi C.L., et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20 (2002) 567-573
14. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17 (1999) 3299-3306
15. Femia R.A., and Goyette R.E. The science of megestrol acetate delivery: potential to improve outcomes in cachexia. Biodrugs 19 (2005) 179-187